results: the median active follow-up times (first to last edss measurement) were as follows: for the interferon beta-treated cohort, 5.1 years (interquartile range [iqr], 3.0-7.0 years); for the contemporary control cohort, 4.0 years (iqr, 2.1-6.4 years); and for the historical control cohort, 10.8 years (iqr, 6.3-14.7 years).